
    
      This is a Phase 1 study designed to assess how the body processes the study drug ABT-199 when
      taken alone and in combination with rifampin and to assess the safety of ABT-199 in
      combination with rifampin. Subjects may enroll in a separate extension study to continue
      receiving ABT-199 after completion of this study.
    
  